Drug Chatter -- Tracking biopharma stock chatter

Profile for Spark Therapeutics, Inc. (ONCE)

« Back to company index

ONCE Chatter Timeline

Stock Ticker for ONCE

Most Active Tweeters for ONCE

UserTweets
@AmericanBanking 11
@skaushi 8
@TriathlonTrader 8
@_B_I_O_T_E_C_H_ 7
@OlympiaReport 7

Recent Tweets for ONCE

skaushi @skaushi
@Bucktweet_Say @odibro I think $once gene therapy is needed for you then ???
January 17th 2018, 11:01pm
WizAtWallSt @WizAtWallSt
Credit Suisse Initiates Coverage On Spark Therapeutics with Outperform Rating, Announces $61.00 Price Target $ONCE
January 17th 2018, 9:01pm
brockthornhill @brockthornhill
RT @skaushi: $ONCE initiated outperform by Credit Suisse PT $61
January 17th 2018, 7:01pm
skaushi @skaushi
$ONCE initiated outperform by Credit Suisse PT $61
January 17th 2018, 7:01pm
TheMarketsDaily @TheMarketsDaily
Wedbush Lowers Spark Therapeutics $ONCE to Underperform https://t.co/09fhKBOYyV
January 17th 2018, 6:01pm
AmericanBanking @AmericanBanking
Spark Therapeutics $ONCE Now Covered by Credit Suisse Group https://t.co/hXxB1Iai8b #stocks
January 17th 2018, 5:01pm
TickerReport @TickerReport
Spark Therapeutics $ONCE Research Coverage Started at Credit Suisse Group https://t.co/9ORwgwN5cS
January 17th 2018, 5:01pm
WeekHerald @WeekHerald
Financial Survey: Spark Therapeutics $ONCE vs. Xenon Pharmaceuticals $XENE https://t.co/rDt87nh3hT
January 17th 2018, 2:01pm
AlexBo6 @AlexBo6
$ONCE its "sparks she keeps running ????
January 17th 2018, 2:01pm
alphabetastock @alphabetastock
Spark Therapeutics Inc $ONCE https://t.co/IiWbhg6rUE
January 17th 2018, 2:01pm
MikeCastaldo1 @MikeCastaldo1
Spark's SPK-8011 an Orphan Drug in U.S. for hemophilia A https://t.co/EsATGdaYBt $ONCE
January 17th 2018, 11:01am
newswelldone @newswelldone
$ONCE: Spark Therapeutics: Challenges Posed By Success: https://t.co/YTtiRTIXcr
January 17th 2018, 10:01am
SeekingAlpha @SeekingAlpha
$ONCE https://t.co/57OxjIRrTl
January 17th 2018, 10:01am
WeekHerald @WeekHerald
Short Interest in Spark Therapeutics Inc $ONCE Expands By 30.0% https://t.co/IZA3r8NkPM
January 17th 2018, 7:01am
HanrattyJim @HanrattyJim
@smartertrader I told you about JUNO weeks ago, just one success story. $ONCE is my next pic, just keep it in mind.
January 17th 2018, 7:01am
WatchlistN @WatchlistN
Short Interest in Spark Therapeutics Inc $ONCE Expands By 30.0% https://t.co/4iIJGPxPyI
January 17th 2018, 2:01am
JasonHolman5 @JasonHolman5
RT @n_yigitbasi: $ONCE FDA grants orphan drug designation to Spark Therapeutics for drug to treat hemophilia A
January 16th 2018, 8:01pm
realmaciej @realmaciej
RT @BiotechHack: $ONCE FDA grants orphan drug designation to Spark Therapeutics for drug to treat hemophilia A
January 16th 2018, 8:01pm
w_biltmore85 @w_biltmore85
@skaushi $ONCE no good bud
January 16th 2018, 7:01pm
tmatty17 @tmatty17
Don’t sleep on $once
January 16th 2018, 6:01pm
StockTexts @StockTexts
$ONCE Spark Therapeutics, Inc. SEC Filing: Form S-8 https://t.co/u3lmw77mx6
January 16th 2018, 5:01pm
filingBot @filingBot
@altafmubaraki there is a new form S-8 filing for $ONCE https://t.co/VglQHUgGrH Share with your friends!
January 16th 2018, 5:01pm
MaisaCorp @MaisaCorp
$ONCE received FDA orphan drug status for its hemophilia A treatment, SPK-8011.
January 16th 2018, 4:01pm
boogiesana @boogiesana
$once - that silly Wedbush downgrade will have cost some investors dearly - the 11 Mill plus fine imposed on Citigr… https://t.co/5fxQNiBBUm
January 16th 2018, 4:01pm
n_yigitbasi @n_yigitbasi
$ONCE FDA grants orphan drug designation to Spark Therapeutics for drug to treat hemophilia A
January 16th 2018, 3:01pm
joaquinkam @joaquinkam
$ONCE FDA grants orphan drug designation to Spark Therapeutics for drug to treat hemophilia A… https://t.co/hIajpm6uRu
January 16th 2018, 3:01pm
MarketCurrents @MarketCurrents
Spark's SPK-8011 an Orphan Drug in U.S. for hemophilia A https://t.co/AtVLBFUZF5 $ONCE
January 16th 2018, 3:01pm
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Spark's SPK-8011 an Orphan Drug in U.S. for hemophilia A https://t.co/GBF0jYrLto $ONCE
January 16th 2018, 3:01pm
monroewarriors5 @monroewarriors5
RT @BiotechHack: $ONCE https://t.co/d5j5Gbvs1L via @AddThis
January 16th 2018, 3:01pm
BiotechHack @BiotechHack
$ONCE https://t.co/d5j5Gbvs1L via @AddThis
January 16th 2018, 3:01pm
monroewarriors5 @monroewarriors5
$ONCE good reversal from 49$, this is the third time it has done that.
January 16th 2018, 3:01pm
alphabetastock @alphabetastock
Spark Therapeutics Inc $ONCE - https://t.co/pVs7QNpGYY
January 16th 2018, 3:01pm
BioPharmaDive @BioPharmaDive
Price for $ONCE gene therapy too high, ICER says https://t.co/DLEqx7v8xq
January 16th 2018, 12:01pm
TriathlonTrader @TriathlonTrader
$ONCE Had so much promise, but the weakness Friday was a tell. Needs to retake the trend line. Until then, I am sta… https://t.co/pV596ralQL
January 16th 2018, 12:01pm
AlertTrade @AlertTrade
UPGRADES & DOWNGRADES ? $ONCE: Wedbush cuts to Underperform https://t.co/cfmw7hkmaO via ? https://t.co/U5xCBHFNAP
January 16th 2018, 11:01am
PennyStocksMomo @PennyStocksMomo
UPGRADES & DOWNGRADES ? $ONCE: Wedbush cuts to Underperform https://t.co/jP0ePYCFq8 via ? https://t.co/900g4SjLiX
January 16th 2018, 11:01am
firsttomarkets @firsttomarkets
Spark Therapeutics Inc Downgrade by Wedbush Morgan (Ranked 56th) to Underperform with $35PT $ONCE #ONCE https://t.co/SjyjNHpht7
January 16th 2018, 11:01am
Briefingcom @Briefingcom
$ONCE: Wedbush cuts to Underperform https://t.co/J4vN2R8eVP
January 16th 2018, 10:01am
joaquinkam @joaquinkam
$ONCE looks like a buying opportunity now ! Disruptive , treatment , and management , a combination almost every… https://t.co/AebCIRyJZT
January 16th 2018, 9:01am
Benzinga @Benzinga
Analyst: Spark Therapeutics' $850,000 Blindness Drug Has Smaller-Than-Expected Market https://t.co/h4l0fKRcIj $ONCE
January 16th 2018, 9:01am
EEthougths @EEthougths
$ONCE fell even below $50, but not surprised at all. Probably stays weak whole day. Not interested in attempting to… https://t.co/oSsRPOIk7n
January 16th 2018, 9:01am
MarketChmln @MarketChmln
$ONCE stock loses -5.1% in premarket VWAP (1 minute interval) Hi 52.00 - Low 49.10 https://t.co/HxDW7nhsSA
January 16th 2018, 9:01am
boogiesana @boogiesana
$ONCE Wedbush target well below price prior approval of Luxtuma - seems a bit silly but helpful if they happen to be short
January 16th 2018, 9:01am
CBPartners @CBPartners
#ICER suggests up to 75% discount for $ONCE #blindness #GeneTherapy LUXTURNA to be cost-effective, but drops this t… https://t.co/QY04jRZJKa
January 16th 2018, 9:01am
ProTradersNews @ProTradersNews
$ONCE: Analyst: Spark Therapeutics’ $850K Blindness Drug Has Smaller …: https://t.co/5Alzcbg5zo
January 16th 2018, 9:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
RT @_B_I_O_T_E_C_H_: WEDBUSH: $ONCE Downgrade to #UNDERPERFORM; Fiat Luxturna? Not Seeing Eye to Eye on Opportunity PT $35.00
January 16th 2018, 9:01am
pharmawhiz @pharmawhiz
$ONCE Wedbush downgrade
January 16th 2018, 8:01am
gawwilson1 @gawwilson1
@_B_I_O_T_E_C_H_ $once In situations like this I always feel like those downgrades are just a way to push the price… https://t.co/f6Y4ii62OX
January 16th 2018, 8:01am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
WEDBUSH: $ONCE Downgrade to #UNDERPERFORM; Fiat Luxturna? Not Seeing Eye to Eye on Opportunity PT $35.00
January 16th 2018, 8:01am
manicwaterfly @manicwaterfly
RT @theflynews: Wedbush cuts Spark Therapeutics to lowest rating with $35 target $ONCE https://t.co/clWE43Wpgz
January 16th 2018, 8:01am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.